CSF1 and Alzheimer disease: More recent data has demonstrated that ablation of microglia in AD mice using a colony-stimulating factor 1 (CSF1) antagonist prevented the formation of these plaques which indicates that microglia may not be responsible for Aβ clearance but may in fact contribute to the initial deposition of Aβ plaques (Spangenberg et al., 2019).